Flavonoid-rich Mediterranean diet for people with multiple sclerosis
Official title: A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis
Run by Hasselt University · NCT07033975 · Data updated 2026-11-12
This trial will test whether following a flavonoid-rich Mediterranean diet can change disease measures and symptoms in adults with multiple sclerosis who have EDSS scores of 0–6.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hasselt University Academic / other |
| Locations | 1 site (Diepenbeek, Limburg) |
| Status | Recruiting |
| Started | April 4, 2023 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT07033975 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a diagnosis of multiple sclerosis who are ambulatory with EDSS between 0 and 6, have no diagnosed digestive disease, and can attend visits at the Hasselt University site.
✕Probably not a fit
People with more advanced disability (EDSS >6), those with diagnosed digestive pathologies, or those unable to follow the dietary program are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study asks participants with multiple sclerosis to follow a flavonoid-enriched Mediterranean dietary pattern to see how nutrition affects disease-related parameters. The protocol focuses on a healthier, plant-forward diet high in flavonoids rather than a drug or device intervention. Outcomes will include clinical measures related to MS and likely biomarkers or symptom measures to capture any change during the intervention. The trial enrolls ambulatory participants (EDSS 0–6) without diagnosed digestive pathology and is conducted at Hasselt University in Diepenbeek, Belgium.
Why it matters
Potential benefit: If successful, the diet could offer a low-risk way to reduce inflammation or symptoms and slow disease-related changes in people with MS.
How similar studies have gone: Observational studies have linked Mediterranean-style diets with better outcomes in MS, but randomized and flavonoid-specific interventional evidence remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Expanded Disability Status Scale (EDSS): 0-6 Exclusion Criteria: * Diagnosed digestive pathology
Where it's running
-
Hasselt University
Diepenbeek, Limburg, Belgium Recruiting
Study contacts
- Study coordinator: Jerome JA Hendriks, Professor
- Email: jerome.hendriks@uhasselt.be
- Phone: +3211269207
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.